| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.1M | — | +13.1% |
| Cost of Revenue | $7.3M | — | +7.4% |
| Gross Profit | $3.8M | — | +25.8% |
| R&D Expense | $609K | — | +10.3% |
| SG&A Expense | $5.1M | — | -7.9% |
| Operating Income | -$4.3M | — | +13.4% |
| Pre-tax Income | -$4.5M | — | +2.5% |
| Income Tax | $47K | — | +113.6% |
| Net Income | -$4.6M | — | +1.9% |
| EPS (Basic) | -$0.08 | — | +11.1% |
| EPS (Diluted) | -$0.08 | — | +11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.3M | -27.2% | +27.5% |
| Short-term Investments | $13.5M | -12.6% | -41.1% |
| Accounts Receivable | $5.7M | +22.8% | +1.0% |
| Inventory | $6.9M | -2.6% | +4.6% |
| Current Assets | $31.7M | -8.2% | -20.3% |
| Total Assets | $98.7M | -4.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | +18.1% |
| Capital Expenditures | $221K | — | +7.3% |
| Investing Cash Flow | $1.8M | — | -51.9% |
| Financing Cash Flow | -$88K | — | -69.2% |
| Free Cash Flow | -$3.6M | — | +16.9% |
| -13.5% |
| Current Liabilities | $6.9M | -8.5% | -2.1% |
| Long-term Debt | $13.2M | +0.4% | +1.4% |
| Total Liabilities | $33.7M | -3.1% | -4.7% |
| Stockholders' Equity | $64.9M | -5.6% | -17.4% |